CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
Published on: Wednesday 27 April 2022
Issuer: CureVac / Key word(s): Quarter Results28.04.2022 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update- Executing on broad vaccine development program, with new clinical studies in COVID-19 and influenza together with GSK to validate advanced second-generation mRNA backbone- Initiated Phase 1 dose-escalation study in COVID-19 with CV2CoV, validating mRNA back
News source: https://uk.finance.yahoo.com/news/curevac-announces-financial-results-fourth-110008928.html
